Biography, Isabelle Koné-Paut

Professor Isabelle Koné-Paut has been the head of the pediatric rheumatology department

at the Kremlin Bicêtre hospital, university of Paris Sud-Saclay. Her department is a EULAR

Center of Excellence (2015/2020 and 2020/2025). Prof Koné-Paut coordinates the national

reference center for rare autoinflammatory diseases and inflammatory amyloidosis

(including seven sites) (CEREMAIA (http://www.ceremaia.fr) since 2007. She has created the

first pediatric inflammatory rheumatism care network (RESRIP: http://www.resrip.fr) in

2012.

Professor Koné-Paut started pediatric rheumatology in 1988 and was the second doctor to

practice this specialty, at the pioneering time, in France. Her clinical research activities began

with a focus on pediatric Behçet's disease and familial Mediterranean fever in a clinico-

genetic duo with Isabelle Touitou. After this time in Marseille, she broadened her research in

Paris to other autoinflammatory diseases and Kawasaki disease. She has personally

developed and collaborated on numerous projects exploring interleukin 1 as a therapeutic

target and patient-reported outcome measures. She has collaborated in various

international organizations and projects: ERN RITA, PRINTO, EUROFEVER, JIR cohort, and

IMMUNAID among others. Professor Koné-Paut has participated in several pedagogic works

and, she is the author of numerous international publications, the most significant of which

concern Pediatric Behçet's disease, familial Mediterranean fever, CAPS syndromes, and

Kawasaki disease. She has held various positions in academic societies: President of

SOFREMIP (French society of pediatric rheumatology), board member of the French Society

of Pediatrics, Pediatric rheumatology European society, International society for

autoinflammatory diseases, and the International Society of Behçet (ISBD). She has set up a

European group for the study of Kawasaki disease: EuroKiDs, and organized the first meeting

in Paris in 2021. Finally, she has received awards: APPINOV trophy (APHP) and Groupama

foundation for the AIDAI score, KOURIR price (EULAR) for the KAWAKINRA Trial, and

MERDOCHAI PRAS AWARD of the ISSAID SOCIETY for clinical science in SAIDs.